Evidence map›Paper›PMID 34765622›Full record

ArticleFrontiers in medicine2021

Serum Human Epididymis Protein 4 as a Novel Biomarker in Identifying Patients With Interstitial Lung Disease in Rheumatoid Arthritis.

Liu Liang, Jiali Chen, Chun Di, Minghua Zhan, Huizhang Bao, Changsheng Xia, Chunhong Fan, Yudong Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 4 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 4 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Liu LiangDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, China.
Jiali ChenDepartment of Rheumatology and Immunology, The Second Xiangya Hospital, Central South University, Changsha, China.
Chun DiDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, China.
Minghua ZhanDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, China.
Huizhang BaoDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, China.
Changsheng XiaDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, China.
Chunhong FanDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, China.
Yudong LiuDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, China.
Peking University · CNPeking University People's Hospital · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerhuman epididymis protein 4interstitial lung diseaserheumatoid arthritisrisk stratification

Identifiers

PMID34765622
PMCPMC8575793
OpenAlexW3209245056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.